Tredje AP fonden decreased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 35.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 197,500 shares of the company’s stock after selling 110,500 shares during the period. Tredje AP fonden’s holdings in Colgate-Palmolive were worth $17,955,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. FMR LLC grew its holdings in Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after buying an additional 2,674,807 shares during the period. AMF Tjanstepension AB grew its holdings in Colgate-Palmolive by 1,088.8% in the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after buying an additional 2,353,268 shares during the period. Barclays PLC grew its holdings in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. State Street Corp grew its holdings in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $132,405,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have commented on the company. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Finally, StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $101.61.
Colgate-Palmolive Stock Performance
Shares of CL opened at $90.71 on Thursday. The business’s 50 day moving average is $89.03 and its two-hundred day moving average is $94.96. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The firm has a market cap of $73.61 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business posted $0.87 EPS. Analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- The 3 Best Fintech Stocks to Buy Now
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.